维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Cudkowicz ME"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Safety and dose escalating study of oral sodium phenylbutyrate in subjects with ALS显示文摘	Cudkowicz ME Andrews PL Choudry R	2007	Neurology2007，68，1：	1
2	Phase 2 study of sodium phenylbutyrate in ALS显示文摘	Cudkowicz ME Andres PL Macdonald SA	2009	Amyotroph Lateral Scler2009，10，2：	1
3	Epidemiology of mutations in superox- ide dismutase in amyotrophic lateral sclerosis显示文摘	Cudkowicz ME McKerma-Yasek D Sapp PE	1997	Ann Neurol1997，41，：	1
4	Dynamic markers of altered gait rhythm in amyotrophyic lateral sclerosis 显示文摘	Hausdorff JM Lertratanakul A Cudkowicz ME	2000	J Appl Physial2000，88，16：	1
5	Trial of celecoxib in amyotrophic lateral sclerosis显示文摘	Cudkowicz ME Shefner JM Schoenfeld DA	2006	Ann Neurol2006，60，1：	1
6	A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis 显示文摘	Cudkowicz ME Shefner JM Schoenfeld DA	2003	Neurology2003，61，4：	1
7	Epidemiology of mutation in superoxide dismutase in amyotrophic lateral sclerosis显示文摘	Cudkowicz ME	1997	Ann Neurol1997，41，2：	1
8	A clinical trial of creatine in ALS 显示文摘	SHEFNER JM CUDKOWICZ ME SCHOENFELD D et ol	2004	Neurology2004，63，9：	1
9	Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis:a multi-stage,randomised,double-blind,placebo-controlled trial显示文摘	Cudkowicz ME Titus S Kearney M	2014	Lancet Neurol2014，13，11：	1
10	Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis显示文摘	CUDKOWICZ ME SHEFNER JM SIMPSON E	2008	Muscle Nerve2008，38，1：	1
11	Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis显示文摘	Cudkowicz ME McKenna-Yasek D Sapp PE	1997	Ann Neurol1997，41，2：	1
12	Clozapine and risperidone treatment of psychosis in Parkinson's disease显示文摘	Ellis T Cudkowicz ME Sexton PM	2000	J Neuropsychiatry Clin Neurosci2000，12，3：	1
13	Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis显示文摘	Cudkowicz ME McKenna-Yasek D Sapp PE	1997	Ann Neurol1997，41，2：	1
14	Gait variabilityand basal ganglia disorders : stride-to-stride variations of gait cycletiming in Parkinson's disease and Huntington's disease显示文摘	Hausdorff JM Cudkowicz ME Firtion R	1998	MovDisord1998，13，42：	1
15	Clozapine and risperidone treatment of psychosis in Parkinson's disease显示文摘	Cudkowicz ME Sexton PM	2000	J Neuropsychiatry Clin Neurosci2000，12，：	1
16	CoenzymeQ treatment of neurodegenera- tire diseases of aging显示文摘	Galper WR Cudkowicz ME	2007	Mitochondrion2007，，：	1
17	Increased CSF F2-isoprostane concentration in probable AD显示文摘	Montine TJ Beal MF Cudkowicz ME	1999	Neurology1999，52，3：	1
18	metabolomic analysis and signatures in motor neuron disease显示文摘	Rozen S Cudkowicz ME Bogdanov M	2005	Metabolomics2005，1，2：	1
19	Epidemiology of mutations in superoxide dismutase in amyot rophic lateral sclerosis显示文摘	Cudkowicz ME Mc Kenna-Yasek D Sapp PE	1997	Ann Neurol1997，41，2：	1
20	Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis显示文摘	Cudkowicz ME McKenna-Yasek D Sapp PE	1997	Ann Neurol1997，41，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示